Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.
Mounjaro approved for blood glucose control in type 2 diabetes
Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.